Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,514.96
(0.5%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)

ACRUX Ltd

ACR

ASX

Acrux Limited (ACR) is an Australian drug delivery company dedicated to developing and commercialising topical pharmaceuticals products for global markets. ACR uses innovative technology to administer medicines through the skin. ACR conducts its operations in Australia, Switzerland, USA and overseas, with three marketed products including Testosterone Solution and Estradiol MDTS.

Latest Posts

Line Chart with Gradient
Price
$0.045
-0.001 (-2.17%)
At Close 22/11 (AEST)
Related Companies
PERCHERON THERAPEUTICS LIMITED
$PER
NOXOPHARM LIMITED
$NOX
DIMERIX LIMITED
$DXB
NANOLLOSE LIMITED
$NC6
HEXIMA LIMITED.
$HXL

Leave a Comment on ACR


Comments for ACR

    Latest Posts

    acrux-asx-acr-outlines-growth-with-fy24-milestones-acr
    Health Care $ACR
    Acrux (ASX: $ACR) outlines growth with FY24 milestonesSpecialty pharmaceutical company eyes US market expansion with new product launches and FDA submissions
    November 21, 2024
    acrux-asx-acr-secures-fda-approval-for-new-gel-acr
    Health Care $ACR
    Acrux (ASX: $ACR) secures FDA approval for new gelPlans to launch Dapsone 7.5% Gel in early 2025 to boost revenue growth
    October 31, 2024
    acrux-asx-acr-receives-fy24-rd-tax-incentive-rebate-acr
    Health Care $ACR

    Acrux (ASX: $ACR) receives FY24 R&D tax incentive rebate

    Successfully repays short term funding facility and gains overseas finding for new development project

    October 2, 2024
    acrux-asx-acr-presents-at-asx-small-and-mid-cap-conference-acr
    Health Care $ACR

    Acrux (ASX: $ACR) presents at ASX small and mid-cap conference

    CEO Michael Kotsanis to discuss Acrux's specialty pharmaceutical products and growth platform

    September 24, 2024
    acrux-asx-acr-secures-short-term-funding-facility-with-radium-capital-acr
    Health Care $ACR

    Acrux (ASX: $ACR) secures short term funding facility with Radium Capital

    Secures non-dilutive short-term funding for R&D Tax Incentive Rebate

    June 28, 2024
    acrux-asx-acr-launches-dapsone-5-gel-in-the-united-states-acr
    Health Care $ACR

    Acrux (ASX: $ACR) launches dapsone 5%, gel in the united states

    Announces launch of generic prescription product for acne vulgaris treatment

    April 3, 2024
    acrux-asx-acr-reports-positive-cashflow-and-increased-reserves-acr
    Health Care $ACR

    Acrux (ASX: $ACR) reports positive cashflow and increased reserves

    Receipt of R&D Tax Incentive and client contracts drive cash surplus

    January 31, 2024

    ACR

    $ACR

    Acrux (ASX: $ACR) outlines growth with FY24 milestones

    Specialty pharmaceutical company eyes US market expansion with new product launches and FDA submissions

    ACR

    $ACR

    Acrux (ASX: $ACR) secures FDA approval for new gel

    Plans to launch Dapsone 7.5% Gel in early 2025 to boost revenue growth

    ACR

    $ACR

    Acrux (ASX: $ACR) receives FY24 R&D tax incentive rebate

    Successfully repays short term funding facility and gains overseas finding for new development project

    ACR

    $ACR

    Acrux (ASX: $ACR) presents at ASX small and mid-cap conference

    CEO Michael Kotsanis to discuss Acrux's specialty pharmaceutical products and growth platform

    ACR

    $ACR

    Acrux (ASX: $ACR) secures short term funding facility with Radium Capital

    Secures non-dilutive short-term funding for R&D Tax Incentive Rebate

    ACR

    $ACR

    Acrux (ASX: $ACR) launches dapsone 5%, gel in the united states

    Announces launch of generic prescription product for acne vulgaris treatment

    ACR

    $ACR

    Acrux (ASX: $ACR) reports positive cashflow and increased reserves

    Receipt of R&D Tax Incentive and client contracts drive cash surplus

    Related Companies
    PROBIOTEC LIMITED
    $PBP
    RADIOPHARM THERANOSTICS LIMITED
    $RAD
    RACE ONCOLOGY LTD
    $RAC
    ANTEOTECH LTD
    $ADO
    ISLAND PHARMACEUTICALS LIMITED
    $ILA

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions